SCHEDULE: Armistice Capital Reports INVO Fertility Stake

Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting beneficial ownership of 120,537 shares of INVO FERTILITY, INC. common stock, representing 4.99% of the class.

Summary

• Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, indicating a change in beneficial ownership of INVO FERTILITY, INC. common stock.
• The reporting persons collectively beneficially own 120,537 shares, which represents 4.99% of the class of securities.
• Armistice Capital, LLC acts as the investment manager for the Master Fund, which is the direct holder of the shares.
• Steven Boyd, as the managing member of Armistice Capital, LLC, may be deemed to beneficially own these shares.
• The filing states that the Master Fund disclaims beneficial ownership due to the investment management agreement with Armistice Capital.
• The filing is an amendment (Amendment No. 2) to a previous filing.
• The date of the event requiring this filing is June 30, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership that keeps the reporting entity just under the 5% threshold, indicating no aggressive stake-building or immediate strategic shift.

Positives

• The reporting persons hold a significant stake, just below the 5% disclosure threshold, suggesting a notable investor presence.
• The filing is current and compliant with SEC regulations.

Negatives

• The filing does not provide any new operational or financial performance data for INVO FERTILITY, INC.

Risks

• The filing does not explicitly mention any risks associated with the investment or the company's operations.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it is a disclosure of beneficial ownership.

Management Comments

• Armistice Capital, LLC is the investment manager of Armistice Capital Master Fund Ltd. (the "Master Fund"), the direct holder of the Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment managers accumulating or adjusting stakes in publicly traded companies. This filing indicates Armistice Capital's continued interest in INVO FERTILITY, INC., maintaining a position just below the 5% reporting threshold.

Comparison to Industry Standards

• This filing is a standard Schedule 13G disclosure, which is a regulatory requirement for significant beneficial ownership of public companies in the United States.
• The 4.99% ownership level is typical for institutional investors who wish to maintain a substantial position without triggering more stringent reporting requirements or signaling a full takeover intent.

Stakeholder Impact

• Shareholders: The filing confirms a significant investor's position, which may influence market perception and trading activity.
• Management: The reporting persons' stake may signal investor scrutiny or potential influence on corporate strategy.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership levels in INVO FERTILITY, INC. and file amendments to Schedule 13G as required by SEC regulations.

Key Dates

Keywords

INVO FERTILITY, Armistice Capital, Schedule 13G, Beneficial Ownership, Investment Management, SEC Filing, Common Stock